PSCL board approves amalgamation of two subsidiaries into itself

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.0%Reaction day

₹3062.00

prior close

₹3174.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.4%+5.6% vs market

Specialty Chemicals peers, median of 89sector+0.3%+6.6% vs sector

On the reaction day the stock moved 5.6 pts more than Nifty Microcap 250 and 6.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.2

15m

-0.4

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.0+1.4+5.6+0.3+6.6

Next day

+7.0+1.4+5.6+0.9+6.1

+9.9+0.9+9.1+0.3+9.6

+6.8+0.3+6.4+0.6+6.2

+2.7-0.4+3.1-0.2+2.9

+5.4-0.5+5.9-0.4+5.8

-8.4+1.1-9.6+0.3-8.8

15d

-11.6-2.5-9.1-2.8-8.8

-11.0-6.1-4.9-6.8-4.2

-2.2-2.8+0.6-6.6+4.4

-5.7-14.9+9.2-19.0+13.2

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 89Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved scheme to merge Privi Fine Sciences (PFSPL) and Privi Biotechnologies (PBPL, wholly owned) into Privi Speciality Chemicals under Sections 230-232 of Companies Act. Share swap ratio: 1 PSCL share for every 135 PFSPL shares. No cash involved. PBPL shares will stand cancelled with no new PSCL shares issued. Subject to NCLT, shareholder and creditor approvals. All entities operate in similar aroma chemicals and biotech space. Rationale: cost savings, vertical integration, operational efficiencies. Post-merger promoter holding drops marginally from 70.64% to 69.89%, public rises to 30.11%.

Likely market impact

Subsidiary consolidation; minor dilution in promoter stake; aims at cost synergies but pending NCLT and shareholder approvals.